BRIEF published on 06/21/2024 at 11:21, 1 year 7 months ago Heidelberg Pharma Reports on the Results of the Annual General Meeting 2024 Shareholders Financial News Resolutions Heidelberg Pharma AGM 2024
PRESS RELEASE published on 06/21/2024 at 11:16, 1 year 7 months ago Heidelberg Pharma reports on the results of the Annual General Meeting 2024 Heidelberg Pharma AG reports on the results of the Annual General Meeting 2024, including approval of resolutions and shareholder attendance Shareholders Voting Results Annual General Meeting 2024 Cancer Therapy Heidelberg Pharma AG
BRIEF published on 06/18/2024 at 13:52, 1 year 7 months ago Heidelberg Pharma AG Announces Updated Guidance for 2024 Revenue Forecast Financial Guidance Biotech Heidelberg Pharma AG Operating Expenses
PRESS RELEASE published on 06/18/2024 at 13:47, 1 year 7 months ago EQS-Adhoc: Heidelberg Pharma AG announces updated guidance Heidelberg Pharma AG updates guidance for fiscal year 2024, lowering sales expectations due to delays and adjusting operating expenses. Financing secured until mid-2025 with potential expansion until end of 2026 Financial Year 2024 Heidelberg Pharma AG Operating Expenses Sales Expectations Updated Guidance
BRIEF published on 05/23/2024 at 09:17, 1 year 7 months ago Heidelberg Pharma to Participate and Present at Upcoming Leading Scientific Conferences in May and June 2024 Cancer Treatment Conférences Heidelberg Pharma HDP-101 ADCs
PRESS RELEASE published on 05/23/2024 at 09:12, 1 year 7 months ago Heidelberg Pharma to Participate and Present at Upcoming Leading Scientific Conferences in May and June 2024 Heidelberg Pharma AG to participate and present at leading scientific conferences in May and June 2024, showcasing innovative ADC technology platforms for cancer treatment Cancer Treatment ADC Technology Heidelberg Pharma AG Scientific Conferences Clinical Stage Biotech
BRIEF published on 04/25/2024 at 07:26, 1 year 8 months ago Heidelberg Pharma AG Reports on Q1 2024 Financials and Operational Progress Financial Performance CEO Appointment Heidelberg Pharma AG HDP-101 Clinical Trial ADC Pipeline Development
PRESS RELEASE published on 04/25/2024 at 07:21, 1 year 8 months ago Heidelberg Pharma AG: Interim Management Statement on the First Three Months of 2024 Heidelberg Pharma AG reports on its interim management statement for the first three months of 2024, including first efficacy data from a clinical trial and successful financing activities Clinical Trial Heidelberg Pharma AG ADC Pipeline Interim Statement Financing Activities
BRIEF published on 04/05/2024 at 09:35, 1 year 9 months ago Heidelberg Pharma to Convene R&D Webinar to Share New Cancer Research Insights Heidelberg Pharma HDP-101 Multiple Myeloma ADCs R&D Webinar
PRESS RELEASE published on 04/05/2024 at 09:30, 1 year 9 months ago Heidelberg Pharma to host R&D Webinar following novel data presented at AACR Heidelberg Pharma AG to host R&D Webinar on 23 April 2024 featuring leading Key Opinion Leaders after presenting novel data at AACR. Event focuses on ADC technologies for cancer treatment Cancer Treatment Heidelberg Pharma AG R&D Webinar ADC Technologies AACR
Published on 01/22/2026 at 13:15, 16 minutes ago Kootenay Silver Announces Bought Deal LIFE Private Placement for Gross Proceeds of C$10.0 Million
Published on 01/22/2026 at 13:15, 16 minutes ago Avino Meets Full Year 2025 Production Guidance; La Preciosa Contributes to Results
Published on 01/22/2026 at 13:05, 26 minutes ago Faraday Copper Intersects Near-Surface Copper Mineralization from Five Drill Holes in the American Eagle Area
Published on 01/22/2026 at 13:00, 31 minutes ago ATHA Energy Announces Upsizing of Convertible Debenture Financing to USD$25 Million
Published on 01/22/2026 at 13:00, 31 minutes ago Rentschler Biopharma appoints Detra Glinatsis as Head of Business Development U.S.
Published on 01/22/2026 at 13:00, 31 minutes ago vVARDIS Advances Sustainable, Drill-Free Caries Management Consistent With WHO’s Forward-Looking Vision for Environmentally Friendly Oral Health
Published on 01/22/2026 at 12:23, 1 hour 7 minutes ago Turkiye Garanti Bankasi A.S.: Brokerage Houses Warrants Initial Sale Prices
Published on 01/22/2026 at 12:20, 1 hour 11 minutes ago Halfords Group PLC: Director/PDMR Shareholding
Published on 01/22/2026 at 11:45, 1 hour 45 minutes ago TradeInn Scales Global Operations: A Tech-Driven Powerhouse Reaching €585M in 2025
Published on 01/22/2026 at 08:45, 4 hours 46 minutes ago Air Liquide voluntary low-carbon electricity sourcing gains momentum, with 3 TWh per year of additional PPAs started in 2025
Published on 01/22/2026 at 08:29, 5 hours 2 minutes ago bioMérieux Acquires Accellix to Elevate Pharmaceutical Quality Control and Accelerate Advanced Therapies
Published on 01/22/2026 at 07:00, 6 hours 31 minutes ago 2025 sales: €918m at constant exchange rates (+4.3%) - €899m at current exchange rates (+2.1%)
Published on 01/21/2026 at 17:40, 19 hours 51 minutes ago Eiffage wins in consortium the contract to replace the steel bridge over the Kiel Canal in Germany
Published on 01/21/2026 at 08:45, 1 day 4 hours ago ENGIE signs a 10-year Biomethane Purchase Agreement with PepsiCo, its first in the United Kingdom
